Debate: Should MRD Monitoring in AML Be Routine? Con

Morphologic review of the bone marrow of patients with Acute Myeloid Leukemia (AML) is used for the assessment of response to therapy. Nadir biopsies are often done to determine if patients should receive additional induction therapy and marrow biopsies on count recovery are done to determine remission status. In order to be considered in morphologic complete remission, patients much have adequate cellularity in the marrow with
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research